Kania Edwin M Jr - Net Worth and Insider Trading

Kania Edwin M Jr Net Worth

The estimated net worth of Kania Edwin M Jr is at least $29 Million dollars as of 2024-11-13. Kania Edwin M Jr is the Director of TransMedics Group Inc and owns about 302,893 shares of TransMedics Group Inc (TMDX) stock worth over $28 Million. Kania Edwin M Jr is the 10% Owner of Moderna Inc and owns about 23,847 shares of Moderna Inc (MRNA) stock worth over $1 Million. Kania Edwin M Jr is also the Director of Cartesian Therapeutics Inc and owns about 19,553 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $331,032. Details can be seen in Kania Edwin M Jr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kania Edwin M Jr has not made any transactions after 2021-11-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Kania Edwin M Jr

Kania Edwin M Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kania Edwin M Jr owns 21 companies in total, including Moderna Inc (MRNA) , TransMedics Group Inc (TMDX) , and Axcella Health Inc (AXLA) among others .

Click here to see the complete history of Kania Edwin M Jr’s form 4 insider trades.

Insider Ownership Summary of Kania Edwin M Jr

Ticker	Comapny	Transaction Date	Type of Owner
MRNA	Moderna Inc	2020-01-14	10 percent owner
TMDX	TransMedics Group Inc	2021-11-29	director
AXLA	Axcella Health Inc	2019-05-08	10 percent owner
		2019-02-27	10 percent owner
		2018-07-17	10 percent owner
		2018-05-08	10 percent owner
		2017-12-06	10 percent owner
		2017-08-17	10 percent owner
		2017-05-16	director
		2016-09-06	10 percent owner
		2016-08-11	10 percent owner
		2016-05-25	10 percent owner
		2015-07-14	10 percent owner
		2015-01-08	director
		2014-08-06	10 percent owner
		2013-07-23	10 percent owner
		2014-02-12	10 percent owner
		2013-09-25	10 percent owner
		2013-03-25	10 percent owner
		2004-07-23	director
		2016-09-06	10 percent owner

Kania Edwin M Jr Latest Holdings Summary

Kania Edwin M Jr currently owns a total of 3 stocks. Among these stocks, Kania Edwin M Jr owns 302,893 shares of TransMedics Group Inc (TMDX) as of November 29, 2021, with a value of $28 Million and a weighting of 95.3%. Kania Edwin M Jr owns 23,847 shares of Moderna Inc (MRNA) as of January 14, 2020, with a value of $1 Million and a weighting of 3.56%. Kania Edwin M Jr also owns 19,553 shares of Cartesian Therapeutics Inc (RNAC) as of May 16, 2017, with a value of $331,032 and a weighting of 1.14%.

Latest Holdings of Kania Edwin M Jr

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TMDX	TransMedics Group Inc	2021-11-29	302,893	91.49	27,711,681
MRNA	Moderna Inc	2020-01-14	23,847	43.47	1,036,629
RNAC	Cartesian Therapeutics Inc	2017-05-16	19,553	16.93	331,032

Holding Weightings of Kania Edwin M Jr

Kania Edwin M Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Kania Edwin M Jr has made a total of 1 transactions in TransMedics Group Inc (TMDX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in TransMedics Group Inc is the acquisition of 100,000 shares on November 29, 2021, which cost Kania Edwin M Jr around $2 Million.

According to the SEC Form 4 filings, Kania Edwin M Jr has made a total of 2 transactions in Moderna Inc (MRNA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Moderna Inc is the sale of 475,000 shares on January 14, 2020, which brought Kania Edwin M Jr around $10 Million.

According to the SEC Form 4 filings, Kania Edwin M Jr has made a total of 0 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years. The most-recent trade in Cartesian Therapeutics Inc is the sale of 8,893 shares on May 16, 2017, which brought Kania Edwin M Jr around $4 Million.

Insider Trading History of Kania Edwin M Jr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kania Edwin M Jr Trading Performance

GuruFocus tracks the stock performance after each of Kania Edwin M Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kania Edwin M Jr is -17.99%. GuruFocus also compares Kania Edwin M Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kania Edwin M Jr within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kania Edwin M Jr's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kania Edwin M Jr

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-6.17
Relative Return to S&P 500(%)	-6.13

Kania Edwin M Jr Ownership Network

Ownership Network List of Kania Edwin M Jr

No Data

Ownership Network Relation of Kania Edwin M Jr

Kania Edwin M Jr Owned Company Details

What does Moderna Inc do?

Who are the key executives at Moderna Inc?

Kania Edwin M Jr is the 10 percent owner of Moderna Inc. Other key executives at Moderna Inc include Chief Financial Officer James M Mock , Chief Legal Officer Shannon Thyme Klinger , and President Stephen Hoge .

Moderna Inc (MRNA) Insider Trades Summary

Over the past 18 months, Kania Edwin M Jr made no insider transaction in Moderna Inc (MRNA). Other recent insider transactions involving Moderna Inc (MRNA) include a net sale of 802,832 shares made by Noubar Afeyan , a net sale of 199,941 shares made by Stephen Hoge , and a net sale of 12,167 shares made by Shannon Thyme Klinger .

In summary, during the past 3 months, insiders sold 4,962 shares of Moderna Inc (MRNA) in total and bought 0 shares, with a net sale of 4,962 shares. During the past 18 months, 1,560,701 shares of Moderna Inc (MRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,560,701 shares.

Moderna Inc (MRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Moderna Inc Insider Transactions

No Available Data

What does TransMedics Group Inc do?

Who are the key executives at TransMedics Group Inc?

Kania Edwin M Jr is the director of TransMedics Group Inc. Other key executives at TransMedics Group Inc include Chief Commercial Officer Tamer I Khayal , director & President & CEO Waleed H Hassanein , and See Remarks Nicholas Corcoran .

TransMedics Group Inc (TMDX) Insider Trades Summary

Over the past 18 months, Kania Edwin M Jr made no insider transaction in TransMedics Group Inc (TMDX). Other recent insider transactions involving TransMedics Group Inc (TMDX) include a net sale of 234,528 shares made by Tamer I Khayal , a net sale of 263,694 shares made by Waleed H Hassanein , and a net sale of 88,963 shares made by Stephen Gordon .

In summary, during the past 3 months, insiders sold 94,626 shares of TransMedics Group Inc (TMDX) in total and bought 0 shares, with a net sale of 94,626 shares. During the past 18 months, 715,374 shares of TransMedics Group Inc (TMDX) were sold and 2,500 shares were bought by its insiders, resulting in a net sale of 712,874 shares.

TransMedics Group Inc (TMDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

TransMedics Group Inc Insider Transactions

No Available Data

What does Axcella Health Inc do?

Who are the key executives at Axcella Health Inc?

Kania Edwin M Jr is the 10 percent owner of Axcella Health Inc. Other key executives at Axcella Health Inc include Senior Vice President & CIPO Paul Fehlner , director & President and CEO William Hinshaw , and 10 percent owner L.p. Fpa, .

Axcella Health Inc (AXLA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Axcella Health Inc (AXLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Axcella Health Inc (AXLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Axcella Health Inc (AXLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Axcella Health Inc Insider Transactions

No Available Data

What does Kaleido Biosciences Inc do?

Who are the key executives at Kaleido Biosciences Inc?

Kania Edwin M Jr is the 10 percent owner of Kaleido Biosciences Inc. Other key executives at Kaleido Biosciences Inc include Chief Medical Officer Alison S Long , Chief Scientific Officer Van Hylckama Vlieg Johan , and director & Chief Executive Officer Daniel L Menichella .

Kaleido Biosciences Inc (KLDO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kaleido Biosciences Inc (KLDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kaleido Biosciences Inc (KLDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kaleido Biosciences Inc (KLDO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kaleido Biosciences Inc Insider Transactions

No Available Data

What does Rubius Therapeutics Inc do?

Who are the key executives at Rubius Therapeutics Inc?

Kania Edwin M Jr is the 10 percent owner of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .

Rubius Therapeutics Inc (RUBY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rubius Therapeutics Inc Insider Transactions

No Available Data

What does Evelo Biosciences Inc do?

Who are the key executives at Evelo Biosciences Inc?

Kania Edwin M Jr is the 10 percent owner of Evelo Biosciences Inc. Other key executives at Evelo Biosciences Inc include Chief Medical Officer Duncan Mchale , See Remarks Mark Bodmer , and Chief Financial Officer Marella Thorell .

Evelo Biosciences Inc (EVLO) Insider Trades Summary

Over the past 18 months, Kania Edwin M Jr made no insider transaction in Evelo Biosciences Inc (EVLO). Other recent insider transactions involving Evelo Biosciences Inc (EVLO) include a net sale of 35,716 shares made by Mark Bodmer , a net sale of 13,391 shares made by Duncan Mchale , and a net sale of 7,814 shares made by Marella Thorell .

In summary, during the past 3 months, insiders sold 0 shares of Evelo Biosciences Inc (EVLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,989 shares of Evelo Biosciences Inc (EVLO) were sold and 5,411,255 shares were bought by its insiders, resulting in a net purchase of 5,373,266 shares.

Evelo Biosciences Inc (EVLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Evelo Biosciences Inc Insider Transactions

No Available Data

What does Quanterix Corp do?

Who are the key executives at Quanterix Corp?

Kania Edwin M Jr is the 10 percent owner of Quanterix Corp. Other key executives at Quanterix Corp include President & Quanterix & Dx Masoud Toloue , Chief Financial Officer Vandana Sriram , and CFO and Treasurer Michael A Doyle .

Quanterix Corp (QTRX) Insider Trades Summary

Over the past 18 months, Kania Edwin M Jr made no insider transaction in Quanterix Corp (QTRX). Other recent insider transactions involving Quanterix Corp (QTRX) include a net sale of 5,500 shares made by Laurie J Olson , a net purchase of 47,000 shares made by David R Walt , and a net purchase of 20,200 shares made by William P Donnelly .

In summary, during the past 3 months, insiders sold 0 shares of Quanterix Corp (QTRX) in total and bought 47,000 shares, with a net purchase of 47,000 shares. During the past 18 months, 5,500 shares of Quanterix Corp (QTRX) were sold and 86,200 shares were bought by its insiders, resulting in a net purchase of 80,700 shares.

Quanterix Corp (QTRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Quanterix Corp Insider Transactions

No Available Data

What does Syros Pharmaceuticals Inc do?

Who are the key executives at Syros Pharmaceuticals Inc?

Kania Edwin M Jr is the 10 percent owner of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Financial Officer Jason Haas , Chief Commercial Officer Chee Conley , and Chief Medical Officer David Roth .

Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary

Over the past 18 months, Kania Edwin M Jr made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Chee Conley .

In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Syros Pharmaceuticals Inc Insider Transactions

No Available Data

What does Cartesian Therapeutics Inc do?

Who are the key executives at Cartesian Therapeutics Inc?

Kania Edwin M Jr is the director of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , director & President & CEO Carsten Brunn , and Chief Scientific Officer Takashi Kei Kishimoto .

Cartesian Therapeutics Inc (RNAC) Insider Trades Summary

Over the past 18 months, Kania Edwin M Jr made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,437,053 shares made by Timothy A Springer , a net purchase of 7,500 shares made by Timothy C Barabe , and a net sale of 2,932 shares made by Carsten Brunn .

In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 205,721 shares, with a net purchase of 205,721 shares. During the past 18 months, 121 shares of Cartesian Therapeutics Inc (RNAC) were sold and 262,014 shares were bought by its insiders, resulting in a net purchase of 261,893 shares.

Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cartesian Therapeutics Inc Insider Transactions

No Available Data

What does Sesen Bio Inc do?

Who are the key executives at Sesen Bio Inc?

Kania Edwin M Jr is the 10 percent owner of Sesen Bio Inc. Other key executives at Sesen Bio Inc include 10 percent owner Modernatx, Inc. , Chief Scientific Officer Michael Klichinsky , and director & President and CEO Steven Kelly .

Sesen Bio Inc (SESN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sesen Bio Inc Insider Transactions

No Available Data

What does Editas Medicine Inc do?

Who are the key executives at Editas Medicine Inc?

Kania Edwin M Jr is the 10 percent owner of Editas Medicine Inc. Other key executives at Editas Medicine Inc include SVP & CHIEF MEDICAL OFFICER Baisong Mei , director & CEO Gilmore Neil O'neill , and EVP & CHIEF SCIENTIFIC OFFICER Linda Burkly .

Editas Medicine Inc (EDIT) Insider Trades Summary

Over the past 18 months, Kania Edwin M Jr made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 1,988 shares made by Bruce Eaton , a net sale of 32,292 shares made by Baisong Mei , and a net sale of 98,056 shares made by Gilmore Neil O'neill .

In summary, during the past 3 months, insiders sold 2,073 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 2,073 shares. During the past 18 months, 166,559 shares of Editas Medicine Inc (EDIT) were sold and 45,000 shares were bought by its insiders, resulting in a net sale of 121,559 shares.

Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Editas Medicine Inc Insider Transactions

No Available Data

What does Seres Therapeutics Inc do?

Who are the key executives at Seres Therapeutics Inc?

Kania Edwin M Jr is the 10 percent owner of Seres Therapeutics Inc. Other key executives at Seres Therapeutics Inc include Chief Scientific Officer Matthew R. Henn , CFO and EVP Eric D. Shaff , and See Remarks Thomas Desrosier .

Seres Therapeutics Inc (MCRB) Insider Trades Summary

Over the past 18 months, Kania Edwin M Jr made no insider transaction in Seres Therapeutics Inc (MCRB). Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 35,175 shares made by Teresa L. Young , a net sale of 33,802 shares made by Eric D. Shaff , and a net sale of 14,878 shares made by Moltke Lisa Von .

In summary, during the past 3 months, insiders sold 31,451 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 31,451 shares. During the past 18 months, 133,982 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,982 shares.

Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Seres Therapeutics Inc Insider Transactions

No Available Data

What does BG Medicine Inc do?

Who are the key executives at BG Medicine Inc?

Kania Edwin M Jr is the 10 percent owner of BG Medicine Inc. Other key executives at BG Medicine Inc include director & 10 percent owner Noubar Afeyan , 10 percent owner Flagship Pioneering Inc. , and 10 percent owner Agtc Advisors Fund Lp .

BG Medicine Inc (BGMD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BG Medicine Inc (BGMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BG Medicine Inc (BGMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BG Medicine Inc (BGMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

BG Medicine Inc Insider Transactions

No Available Data

What does Acceleron Pharma Inc do?

Who are the key executives at Acceleron Pharma Inc?

Kania Edwin M Jr is the director of Acceleron Pharma Inc. Other key executives at Acceleron Pharma Inc include EVP & Chief Commercial Officer Sujay Kango , SVP & CFO and Treasurer Kevin F Mclaughlin , and SVP & General Counsel and Sec. Adam M Veness .

Acceleron Pharma Inc (XLRN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acceleron Pharma Inc (XLRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acceleron Pharma Inc (XLRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acceleron Pharma Inc (XLRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Acceleron Pharma Inc Insider Transactions

No Available Data

What does T2 Biosystems Inc do?

Who are the key executives at T2 Biosystems Inc?

Kania Edwin M Jr is the 10 percent owner of T2 Biosystems Inc. Other key executives at T2 Biosystems Inc include 10 percent owner Cr Group L.p. , 10 percent owner Crg Partners Iii (cayman) Unlev Aiv I L.p. , and 10 percent owner Crg Partners Iii (cayman) Lev Aiv I L.p. .

T2 Biosystems Inc (TTOO) Insider Trades Summary

Over the past 18 months, Kania Edwin M Jr made no insider transaction in T2 Biosystems Inc (TTOO). Other recent insider transactions involving T2 Biosystems Inc (TTOO) include a net sale of 48,345,798 shares made by Cr Group L.p. , and a net sale of 55 shares made by David B Elsbree .

In summary, during the past 3 months, insiders sold 55 shares of T2 Biosystems Inc (TTOO) in total and bought 0 shares, with a net sale of 55 shares. During the past 18 months, 483,513 shares of T2 Biosystems Inc (TTOO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 483,513 shares.

T2 Biosystems Inc (TTOO)'s detailed insider trading history can be found in Insider Trading Tracker table.

T2 Biosystems Inc Insider Transactions

No Available Data

What does Agios Pharmaceuticals Inc do?

Who are the key executives at Agios Pharmaceuticals Inc?

Kania Edwin M Jr is the 10 percent owner of Agios Pharmaceuticals Inc. Other key executives at Agios Pharmaceuticals Inc include Chief Financial Officer Cecilia Jones , director & Chief Executive Officer Brian Goff , and Chief Medical Officer Sarah Gheuens .

Agios Pharmaceuticals Inc (AGIO) Insider Trades Summary

Over the past 18 months, Kania Edwin M Jr made no insider transaction in Agios Pharmaceuticals Inc (AGIO). Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 9,416 shares made by Washburn Theodore James Jr. , a net sale of 64,534 shares made by Brian Goff , and a net sale of 14,160 shares made by James William Burns .

In summary, during the past 3 months, insiders sold 2,542 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 2,542 shares. During the past 18 months, 252,596 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 252,596 shares.

Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Agios Pharmaceuticals Inc Insider Transactions

No Available Data

What does Concert Pharmaceuticals Inc do?

Who are the key executives at Concert Pharmaceuticals Inc?

Kania Edwin M Jr is the 10 percent owner of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include Chief Development Officer James V Cassella , CFO & PFO Marc A. Becker , and Chief Operating Officer Nancy Stuart .

Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Concert Pharmaceuticals Inc Insider Transactions

No Available Data

What does DNIB Unwind Inc do?

Who are the key executives at DNIB Unwind Inc?

Kania Edwin M Jr is the 10 percent owner of DNIB Unwind Inc. Other key executives at DNIB Unwind Inc include director & other: Chairman Daniel Lynch , Chief Scientific Officer Jonathan Michael Yingling , and director & PRESIDENT & CEO Andrew Hirsch .

DNIB Unwind Inc (BINDQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DNIB Unwind Inc (BINDQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DNIB Unwind Inc (BINDQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DNIB Unwind Inc (BINDQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

DNIB Unwind Inc Insider Transactions

No Available Data

What does Tetraphase Pharmaceuticals Inc do?

Who are the key executives at Tetraphase Pharmaceuticals Inc?

Kania Edwin M Jr is the 10 percent owner of Tetraphase Pharmaceuticals Inc. Other key executives at Tetraphase Pharmaceuticals Inc include director & See Remarks Larry G. Edwards , director & 10 percent owner Steven Boyd , and director & 10 percent owner Armistice Capital Master Fund Ltd. .

Tetraphase Pharmaceuticals Inc (TTPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tetraphase Pharmaceuticals Inc (TTPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tetraphase Pharmaceuticals Inc Insider Transactions

No Available Data

What does Exact Sciences Corp do?

Who are the key executives at Exact Sciences Corp?

Kania Edwin M Jr is the director of Exact Sciences Corp. Other key executives at Exact Sciences Corp include Gen. Mgr. & Precision Oncology Brian Baranick , General Counsel James Herriott , and director & Vice President Kevin T Conroy .

Exact Sciences Corp (EXAS) Insider Trades Summary

Over the past 18 months, Kania Edwin M Jr made no insider transaction in Exact Sciences Corp (EXAS). Other recent insider transactions involving Exact Sciences Corp (EXAS) include a net sale of 20,284 shares made by Sarah Condella , a net sale of 11,459 shares made by Brian Baranick , and a net sale of 5,403 shares made by James Herriott .

In summary, during the past 3 months, insiders sold 1,858 shares of Exact Sciences Corp (EXAS) in total and bought 0 shares, with a net sale of 1,858 shares. During the past 18 months, 170,352 shares of Exact Sciences Corp (EXAS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 170,352 shares.

Exact Sciences Corp (EXAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Exact Sciences Corp Insider Transactions

No Available Data

What does CARISMA Therapeutics Inc do?

Who are the key executives at CARISMA Therapeutics Inc?

Kania Edwin M Jr is the 10 percent owner of CARISMA Therapeutics Inc. Other key executives at CARISMA Therapeutics Inc include 10 percent owner Modernatx, Inc. , Chief Scientific Officer Michael Klichinsky , and Chief Financial Officer Richard Steven Morris .

CARISMA Therapeutics Inc (CARM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CARISMA Therapeutics Inc (CARM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CARISMA Therapeutics Inc (CARM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CARISMA Therapeutics Inc (CARM)'s detailed insider trading history can be found in Insider Trading Tracker table.

CARISMA Therapeutics Inc Insider Transactions

No Available Data

Kania Edwin M Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Kania Edwin M Jr. Currently GuruFocus does not have mailing address information for Kania Edwin M Jr.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.